Skip to main content
Clinical Trials/JPRN-UMIN000004074
JPRN-UMIN000004074
Not yet recruiting
未知

A study on recombinant thrombomodulin alfa in patients with disseminated intravascular coagulation (DIC) caused by sepsis receiving continuous hemodiafiltration (CHDF). - A study on recombinant thrombomodulin for septic DIC patients receiving CHDF.

Chiba University Graduate School of Medicine0 sites20 target enrollmentSeptember 1, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Disseminated intravascular coagulation (DIC)
Sponsor
Chiba University Graduate School of Medicine
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2010
End Date
March 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Chiba University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Chronic kidney disease 2\. Patients showing intracranial, pulmonary or gastrointestinal hemorrhage. 3\. Patients with a history of hypersensitivity to rTM. 4\. Pregnant women, nursing mothers or possibly pregnant women. 5\. Other patients judged to be inappropriate at the discretion of investigators.

Outcomes

Primary Outcomes

Not specified

Similar Trials